US Patent Issued to Tufts Medical Center on Jan. 20 for "Methods and compositions for preventing and treating metabolic syndrome induced by antipsychotic treatment and related diseases and conditions" (Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,754, issued on Jan. 20, was assigned to Tufts Medical Center Inc. (Boston).

"Methods and compositions for preventing and treating metabolic syndrome induced by antipsychotic treatment and related diseases and conditions" was invented by Gregory Oxenkrug (Newton, Mass.) and Paul Summergrad (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods and compositions for use in the prevention and treatment of antipsychotic medication-induced metabolic syndrome (MetS) and diseases and conditions related to MetS."

The patent was filed on June 28, 2019, under Application No. 17/256,321.

*For further information, including image...